DoVE Return on Investment (ROI) Publication Launch

The Decade of Vaccine Economics (DoVE) project, carried out by the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center (IVAC) for nearly ten years, has computed the return-on-investment (ROI) for vaccines preventing 10 infectious diseases in 73 countries that have received support from Gavi, the Vaccine Alliance.

In August 2020, the results of DoVE were released and also published on Health Affairs. Some of the key study findings include:

• Between 2021 and 2030, vaccine programs in 73 low- and middle- income countries will prevent over $782 billion in costs associated with diseases.

• Return on investment in vaccine programs is estimated to be US$54 per $1 spent when considering value individuals place on their health.

• Using a Cost of Illness approach, the estimated net benefit would be about 20 times the cost of vaccine programs.

Two ways to show vaccines are a smart investment

1. DoVE compared the costs of providing vaccines against 10 diseases to the economic benefits of vaccines in 73 low- and middle-income countries from 2021–2030.

2. Using a Cost of Illness approach, the estimated net benefit would be about 20 times the cost of vaccine programs. Using a Value of a Statistical Life approach, the net-benefit versus cost ratio for the same decade would be more than 50 to 1. By comparison, publicly-traded American companies in the S&P 500 have returned an average of $2.16 for every $1 invested after 10 years.

Other Resources

Visit DoVE’s website – The Value of Vaccine Programs

Commentary on Gavi’s #VaccinesWork blog

Full publication on Health Affairs

Sample Tweets from the Social Media Toolkit

DYK monetary value can be placed on preventing illness through #vaccination💧💉? New #DoVE2020 study finds that from 2021-2030, every US$1 invested in #vaccine programs will return $54 of benefits when considering value people place on their health. Visit www.vaccineroi.org

Preventing illness through #vaccinating a child👶🏻👧🏽🧒🏿 has major economic benefits💰. New estimates from the #DoVE2020 team show that the total costs of illness heavily outweigh the cost of vaccinating a child. Learn more at vaccineroi.org #VaccinesWork

Using data on how much individuals would pay to avoid a small risk of death from vaccine-preventable diseases, the #DoVE2020 study found that every💲invested in #vaccine programs💧💉 returns US$54 in economic benefits💰. View the results at vaccineroi.org. #VaccinesWork